Related references
Note: Only part of the references are listed.Short-term treadmill exercise increased tau insolubility and neuroinflammation in tauopathy model mice
Montasir Elahi et al.
NEUROSCIENCE LETTERS (2016)
Alteration in amyloid β42, phosphorylated tau protein, interleukin 6, and acetylcholine during diabetes-accelerated memory dysfunction in diabetic rats: correlation of amyloid β42 with changes in glucose metabolism
You Zhou et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2015)
Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
Michael J. Kraakman et al.
CELL METABOLISM (2015)
The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties
Shin-Ei Matsumoto et al.
HUMAN MOLECULAR GENETICS (2015)
Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity
Susan L. Patterson
NEUROPHARMACOLOGY (2015)
Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative Stress
Susan A. Austin et al.
PLOS ONE (2015)
Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
Sergio T. Ferreira et al.
ALZHEIMERS & DEMENTIA (2014)
NADPH Oxidase 1, a Novel Molecular Source of ROS in Hippocampal Neuronal Death in Vascular Dementia
Dong-Hee Choi et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
Fernanda G. De Felice et al.
DIABETES (2014)
Persistent mechanical allodynia positively correlates with an increase in activated microglia and increased P-p38 mitogen-activated protein kinase activation in streptozotocin-induced diabetic rats
K. -I. Cheng et al.
EUROPEAN JOURNAL OF PAIN (2014)
Activated microglia in the spinal cord underlies diabetic neuropathic pain
Dongmei Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
The mitochondrial O-linked N-acetylglucosamine transferase (mOGT) in the diabetic patient could be the initial trigger to develop Alzheimer disease
Liliana Lozano et al.
EXPERIMENTAL GERONTOLOGY (2014)
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress
Georgia E. Hodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Insulin dysfunction and Tau pathology
Noura B. El Khoury et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Microglial pathology
Wolfgang J. Streit et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Sustained Interleukin-1β Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model
Simantini Ghosh et al.
JOURNAL OF NEUROSCIENCE (2013)
Microglia Multiple roles in surveillance, circuit shaping, and response to injury
Eduardo E. Benarroch
NEUROLOGY (2013)
Review: Microglia of the aged brain: primed to be activated and resistant to regulation
D. M. Norden et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Review: Activation patterns of microglia and their identification in the human brain
D. Boche et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Betaine Alleviates Hypertriglycemia and Tau Hyperphosphorylation in db/db Mice
Go-young Jung et al.
TOXICOLOGICAL RESEARCH (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice
Ashley M. Fenn et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice
Markus Britschgi et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Minocycline attenuates the development of diabetic neuropathic pain: Possible anti-inflammatory and anti-oxidant mechanisms
Kavita Pabreja et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer's Disease Model
Masashi Kitazawa et al.
JOURNAL OF IMMUNOLOGY (2011)
Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models
M. C. Deeds et al.
LABORATORY ANIMALS (2011)
Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice
Taiki Kambe et al.
NEUROBIOLOGY OF DISEASE (2011)
How does diabetes accelerate Alzheimer disease pathology?
Catrina Sims-Robinson et al.
NATURE REVIEWS NEUROLOGY (2010)
Insulin resistance is associated with the pathology of Alzheimer disease The Hisayama Study
T. Matsuzaki et al.
NEUROLOGY (2010)
Regulation of Tau Pathology by the Microglial Fractalkine Receptor
Kiran Bhaskar et al.
NEURON (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease
Wolfgang J. Streit et al.
ACTA NEUROPATHOLOGICA (2009)
Different Patterns of Cerebral Injury in Dementia With or Without Diabetes
Joshua A. Sonnen et al.
ARCHIVES OF NEUROLOGY (2009)
Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines
Christopher J. Henry et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Increased Tau Phosphorylation and Cleavage in Mouse Models of Type 1 and Type 2 Diabetes
Bhumsoo Kim et al.
ENDOCRINOLOGY (2009)
Risk of Incident Alzheimer's Disease in Diabetic Patients: A Systematic Review of Prospective Trials
Daniel Kopf et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Oxidative Stress in Diabetes and Alzheimer's Disease
V. Prakash Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease
Ying Liu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
Yazi D. Ke et al.
PLOS ONE (2009)
Defective Insulin Signaling Pathway and Increased Glycogen Synthase Kinase-3 Activity in the Brain of Diabetic Mice: Parallels With Alzheimer's Disease and Correction by Insulin
C. G. Jolivalt et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms
Emmanuel Planel et al.
JOURNAL OF NEUROSCIENCE (2007)
Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation
Fei Liu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Positron emission tomography imaging in dementia
K. Herholz et al.
BRITISH JOURNAL OF RADIOLOGY (2007)
Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency
Buffie J. Clodfelder-Miller et al.
DIABETES (2006)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
C-terminal truncation modulates both nucleation and extension phases of τ fibrillization
HS Yin et al.
FEBS LETTERS (2006)
Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies
T Cukierman et al.
DIABETOLOGIA (2005)
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease
M Kitazawa et al.
JOURNAL OF NEUROSCIENCE (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Q Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway
RA Quintanilla et al.
EXPERIMENTAL CELL RESEARCH (2004)
Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein
A Bellucci et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Regulation of glycogen synthase kinase-3β by products of lipid peroxidation in human neuroblastoma cells
B Dozza et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells
JB Choi et al.
DIABETOLOGIA (2003)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation
JG Sheng et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal
M Pérez et al.
FEBS LETTERS (2000)
Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-κB
JRR Heyen et al.
MOLECULAR BRAIN RESEARCH (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
